We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $468M Turnover 12.5%
1-Year Est. Return 6.67%
This Fund
S&P 500
This Quarter Est. Return
+3.08%
1 Year Est. Return
+6.67%
3 Year Est. Return
+57.25%
5 Year Est. Return
+83.16%
10 Year Est. Return
+253.32%
AUM
$464M
AUM Growth
+$254K
Cap. Flow
-$11.5M
Cap. Flow %
-2.48%
Top 10 Hldgs %
46.69%
Holding
69
New
–
Increased
32
Reduced
23
Closed
5
Avg Time Held
2.5 years
Top 10 Avg Time Held
1.3 years
Top 20 Avg Time Held
1.6 years

Top Buys

Rank Stock Value
1
GNTX icon
Gentex
GNTX
+$5.51M
2
WBA icon
Walgreens Boots Alliance
WBA
+$4.42M
3
PEP icon
PepsiCo
PEP
+$2.84M
4
WFC icon
Wells Fargo
WFC
+$1.71M
5
COL
Rockwell Collins
COL
+$1.67M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$14.9M
2
VZ icon
Verizon
VZ
+$9.42M
3
BHI
Baker Hughes
BHI
+$3.91M
4
BAX icon
Baxter International
BAX
+$3.16M
5
SYT
Syngenta Ag
SYT
+$2.5M

Sector Composition

Rank Sector Weight
1 Healthcare 29.4%
2 Technology 18.16%
3 Industrials 17.16%
4 Financials 12.21%
5 Consumer Staples 10.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CHRW icon
26
C.H. Robinson
CHRW
$16B
$5.79M 1.25%
84,239
+17,353
+26% +$1.23M
2016 Q3
3 quarters
SABR icon
27
Sabre
SABR
$694M
$5.69M 1.23%
261,238
+11,429
+5% +$260K
2017 Q1
1 quarter
MRK icon
28
Merck
MRK
$362B
$5.08M 1.1%
83,105
-654
-0.8% -$39.8K
2013 Q2
16 quarters
NVO icon
29
Novo Nordisk
NVO
$173B
$4.91M 1.06%
229,062
-5,722
-2% -$115K
2016 Q4
2 quarters
HSY icon
30
Hershey
HSY
$34.4B
$4.85M 1.05%
45,205
+7,458
+20% +$823K
2016 Q3
3 quarters
UNH icon
31
UnitedHealth
UNH
$360B
$4.23M 0.91%
22,826
+6,414
+39% +$1.12M
2016 Q4
2 quarters
KO icon
32
Coca-Cola
KO
$402B
$4.2M 0.91%
93,720
– –
2013 Q2
16 quarters
SWK icon
33
Stanley Black & Decker
SWK
$14.1B
$4.16M 0.9%
29,571
-215
-0.7% -$29.5K
2013 Q4
14 quarters
DOX icon
34
Amdocs
DOX
$6.27B
$3.96M 0.85%
61,369
-980
-2% -$61.9K
2013 Q2
16 quarters
OUT icon
35
Outfront Media
OUT
$5.37B
$3.93M 0.85%
172,614
-789
-0.5% -$18.7K
2016 Q2
4 quarters
BG icon
36
Bunge Global
BG
$20.5B
$3.79M 0.82%
50,806
-4,878
-9% -$371K
2013 Q3
15 quarters
PX icon
37
DELISTED
Praxair Inc
PX
$3.79M 0.82%
28,579
+7,590
+36% +$973K
2016 Q1
5 quarters
HOG icon
38
Harley-Davidson
HOG
$2.82B
$3.63M 0.78%
67,097
-532
-0.8% -$29.6K
2016 Q1
5 quarters
EMR icon
39
Emerson Electric
EMR
$90.1B
$3.48M 0.75%
58,360
+9
+0% +$534
2015 Q2
8 quarters
TTE icon
40
TotalEnergies
TTE
$200B
$3.44M 0.74%
69,265
+8,560
+14% +$440K
2017 Q1
1 quarter
UL icon
41
Unilever
UL
$142B
$3.42M 0.74%
56,183
-12,362
-18% -$737K
2016 Q4
2 quarters
LHX icon
42
L3Harris
LHX
$45.4B
$3.28M 0.71%
30,062
+12,014
+67% +$1.32M
2016 Q3
3 quarters
RDS.A
43
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$3.26M 0.7%
61,313
-1,948
-3% -$103K
2013 Q3
15 quarters
BRK.B icon
44
Berkshire Hathaway Class B
BRK.B
$1.13T
$2.77M 0.6%
16,323
– –
2013 Q2
16 quarters
AN icon
45
AutoNation
AN
$5.38B
$2.66M 0.57%
63,078
-7,148
-10% -$291K
2016 Q3
3 quarters
BHI
46
DELISTED
Baker Hughes
BHI
$2.64M 0.57%
48,385
-68,016
-58% -$3.91M
2016 Q3
3 quarters
MDLZ icon
47
Mondelez International
MDLZ
$81.8B
$2.39M 0.51%
55,256
– –
2013 Q2
16 quarters
CCU icon
48
Compañía de Cervecerías Unidas
CCU
$2.01B
$2.05M 0.44%
78,111
+730
+0.9% +$19K
2014 Q2
12 quarters
KT icon
49
KT
KT
$8.74B
$1.78M 0.38%
106,843
+970
+0.9% +$15.8K
2013 Q3
15 quarters
VZ icon
50
Verizon
VZ
$186B
$1.66M 0.36%
37,269
-202,205
-84% -$9.42M
2014 Q4
10 quarters
1
2
3

Similar funds

GC
Guidance Capital Lousville, Kentucky $468M AUM 26.09% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
THC
Truffle Hound Capital Bethesda, Maryland $468M AUM 42.57% 1-Year Est. Return
STCG
Speece Thorson Capital Group Minnetonka, Minnesota $468M AUM 19.67% 1-Year Est. Return
BAM
Brave Asset Management Summit, New Jersey $467M AUM 33.05% 1-Year Est. Return
TOCUITCONY
Trustees of Columbia University in the City of New York New York $468M AUM 20.53% 1-Year Est. Return
MB
Mizuho Bank Tokyo, Japan $467M AUM 24.01% 1-Year Est. Return
TAM
Talaria Asset Management Melbourne, Australia $467M AUM 14.07% 1-Year Est. Return

Foyston, Gordon, & Payne's Q2 2017 Portfolio in Review

As of Q2 2017, Foyston, Gordon, & Payne held 69 positions worth $464M, up 0.05% from $464M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Foyston, Gordon, & Payne's Q2 2017 filing shows 32 increased, 23 reduced and 5 closed positions. The largest sale was Medtronic, an estimated $14.9M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 30% a quarter earlier, followed by Technology and Industrials.

  • Foyston, Gordon, & Payne added most to Gentex in Q2 2017, an estimated $5.51M increase.
  • Foyston, Gordon, & Payne's biggest Q2 2017 reduction was Medtronic, cutting an estimated $14.9M.
  • Foyston, Gordon, & Payne fully exited Syngenta Ag in Q2 2017, selling an estimated $2.5M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 47% of its $464M portfolio in Q2 2017.
  • Foyston, Gordon, & Payne opened 0 new positions and closed 5 in Q2 2017.
  • Foyston, Gordon, & Payne's portfolio value rose 0.05% quarter-over-quarter to $464M.

Based on Foyston, Gordon, & Payne's 13F filing for Q2 2017, filed 14 Aug 2017.